GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Margin of Safety % (DCF Earnings Based)

4d pharma (4d pharma) Margin of Safety % (DCF Earnings Based) : N/A (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is 4d pharma Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

4d pharma's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


Competitive Comparison of 4d pharma's Margin of Safety % (DCF Earnings Based)

For the Biotechnology subindustry, 4d pharma's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4d pharma's Margin of Safety % (DCF Earnings Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where 4d pharma's Margin of Safety % (DCF Earnings Based) falls into.



4d pharma Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of 4d pharma's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


4d pharma (4d pharma) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Margin of Safety % (DCF Earnings Based)
Traded in Other Exchanges
N/A
Address
9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (4d pharma) Headlines

From GuruFocus

4D pharma Announces $30 Million Credit Facility with Oxford Finance

By Business Wire Business Wire 07-29-2021

4D pharma to Present at the H.C. Wainwright Global Investment Conference

By Business Wire Business Wire 05-19-2022

4D Pharma to Present at Upcoming Investor Conferences in March

By Business Wire Business Wire 03-03-2021

Update on Suspension of Trading

By Business Wire Business Wire 06-24-2022